Morepen Laboratories Limited has received USFDA approval for its anti-allergy drug Fexofinadine Hydrochloride that is market in India under the popular brand name Allegra, among others and is the block buster drug of the innovator company Sanofi Aventis, France. Fexofinadine is most widely used, second generation antihistamine drug for the treatment of allergy symptoms and hay fever.
- Read more about Morepen gets USFDA Approval for Fexofinadine (Allegra)
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/morepen-gets-usfda-approval-for-fexofinadine-allegra
No comments:
Post a Comment